Manny Parra, who was non-tendered by the Brewers in November, has agreed to a one-year deal with the Reds.
Parra was often a mess as a starter and didn’t exactly thrive shifting to the bullpen last season with a 5.06 ERA and terrible control, but he did manage 61 strikeouts in 59 innings and has some upside as a left-handed middle man.
Overall he has a 5.61 ERA since 2009, so at age 30 this is a big season for Parra’s career as he tries to prolong his stay in the majors as a reliever.
UPDATE: Ken Rosenthal of FOXSports.com says the deal is worth $1 million, plus another $400,000 in incentives. Not bad considering he made $1.3 million last year.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.